Triple-negative breast cancer (TNBC) is characterized by estrogen receptor (ER) and progesterone receptor (PR) negative, and lack of human epidermal growth factor receptor type 2 overexpression, accounting for 10%–20% of breast cancer cases. The gene discussed is ESR1; the disease is triple-negative breast carcinoma.